Response of CBA/N mice to human B cell activating factor.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D001402:B-Lymphocytes / Q000276:immunology*; D001688:Biological Products / Q000494:pharmacology; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D005362:Ficoll / Q000276:immunology; D008040:Genetic Linkage; D008222:Lymphokines / Q000494:pharmacology*; D051379:Mice; D008808:Mice, Inbred CBA / Q000276:immunology; D009154:Mutation; D009578:Nitrobenzenes / Q000276:immunology; D013154:Spleen / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014960:X Chromosome
D001688:Biological Products; D008222:Lymphokines; D009578:Nitrobenzenes; D005362:Ficoll